Table 3 |
|||||
|
Summary of evaluation |
|||||
|
Protein name |
Partner protein name |
PROFbval1 |
POODLE-S2 |
FlexPred1 |
Proposed method |
|
|
|||||
|
Staphylococcus A |
Human Fc fragment |
× |
○ |
× |
○ |
|
|
|||||
|
Ran GTPase |
RCC1 |
× |
○ |
× |
○ |
|
|
|||||
|
14-3-3 |
Serotonin N-acteylase |
○ |
○ |
× |
○ |
|
|
|||||
|
Actin |
Profilin |
× |
× |
× |
× |
|
|
|||||
|
Erythropoietin |
EPO receptor |
× |
○ |
○ |
○ |
|
|
|||||
|
Fab fragment |
Flu virus hemagglutinin |
○ |
× |
× |
○ |
|
|
|||||
|
TGF-beta |
TGF-beta receptor |
× |
○ |
○ |
○ |
|
|
|||||
|
Actin |
Dnase I |
× |
× |
× |
× |
|
|
|||||
|
Coagulation factor Vlla |
Soluble tissue factor |
○ |
× |
× |
○ |
|
|
|||||
|
Ran GTPase |
Importin-beta |
× |
× |
× |
○ |
|
|
|||||
|
HPr kinase C-ter domain |
HPr |
○ |
○ |
○ |
○ |
|
|
|||||
|
HIV1 reverse transcriptase |
Fab28 |
○ |
○ |
× |
○ |
|
|
|||||
|
Ecotin |
D102N trypsin |
○ |
○ |
○ |
○ |
|
|
|||||
|
EPO receptor |
Erythropoietin |
× |
× |
× |
○ |
|
|
|||||
|
Vitamin D bindings |
Actin |
○ |
× |
○ |
○ |
|
|
|||||
|
Nitrogenase Fe |
Nitrogenase Mo-Fe protein |
○ |
× |
× |
○ |
|
|
|||||
|
CDK2 kinase |
CDK inhibitor 3 |
× |
× |
× |
○ |
|
|
|||||
|
Gelsolin |
Actin |
○ |
○ |
○ |
○ |
|
|
|||||
|
Importin-beta |
Ran GTPase |
○ |
× |
× |
○ |
|
|
|||||
|
Hirustatin |
Kallikrein |
× |
× |
× |
× |
|
|
|||||
|
'○' means that the predictor detects at least one overlap between the observed conformational change region and predicted high motion region. Conversely, '×' means that there is no overlap. PROFbval, POODLE-S, and FlexPred were performed with the default parameters; then candidate conformational change regions were determined as follows. 1 Three or more consecutive residues predicted to be flexible. 2 Disordered region longer than three residues. |
|||||
|
Hirose et al. BMC Structural Biology 2010 10:20 doi:10.1186/1472-6807-10-20 |
|||||